What was disputed, and how it came out
Each issue the panel decided, with the reasoning it gave. An outcome is what this panel did on this record — not a rule, and not a prediction.
The facts that decided it
What the panel treated as outcome-determinative, and which side it favoured.
The Stipulated Award clearly included future medical care for skin cancer without any limiting language.
Favours Applicant prevailed
This established that the defendant was obligated to authorize treatment promptly without delay.
From the decision · page 7The Stipulated Award includes future medical care for skin cancer, without any limiting language. The Court's December 14, 2020 Findings and Order notes, "The facts here, however, demonstrate that there was no ambiguity concerning the language of the Stipulations with Request for Award. There was no ambiguity that the treatment in question was for skin cancer and that the Applicant received an Award for future medical care for skin cancer. Consequently, Defendant was obligated to authorize the medical treatment promptly. [In the alternative, Defendant could have sent
Defendant's claims manager delayed authorization by requiring non-industrial basis clarification despite clear stipulations.
Favours Applicant prevailed
This delay was unreasonable given the clear stipulations and led to the penalty.